Literature DB >> 2928797

Histamine is an intracellular messenger mediating platelet aggregation.

S P Saxena1, L J Brandes, A B Becker, K J Simons, F S LaBella, J M Gerrard.   

Abstract

Inhibition of human platelet aggregation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl (DPPE), a novel antagonist of histamine binding, suggested that histamine might serve a critical role in cell function. Phorbol-12-myristate-13-acetate (PMA) or collagen was found to increase platelet histamine content in parallel with promotion of aggregation. Inhibitors of histidine decarboxylase (HDC) suppressed both aggregation and the elevation of histamine content, whereas DPPE inhibited aggregation only. In saponin-permeabilized platelets, added histamine reversed the inhibition by DPPE or HDC inhibitors on aggregation induced by PMA or collagen. The results indicate a role for histamine as an intracellular messenger, which in platelets promotes aggregation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928797     DOI: 10.1126/science.2928797

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

1.  Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.

Authors:  Wai Ho Tang; Jeremiah Stitham; Scott Gleim; Concetta Di Febbo; Ettore Porreca; Cristiano Fava; Stefania Tacconelli; Marta Capone; Virgilio Evangelista; Giacomo Levantesi; Li Wen; Kathleen Martin; Pietro Minuz; Jeffrey Rade; Paola Patrignani; John Hwa
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

2.  A place for free radicals in platelet-derived histamine releasing factor (PDHRF) and evidence that histaminergic receptors modulate platelet aggregation.

Authors:  P F Mannaioni; A Pistelli; F Gambassi; M G Di Bello; S Raspanti; E Masini
Journal:  Agents Actions       Date:  1991-05

3.  High affinity histamine-binding and antihistaminic activity of the salivary nitric oxide-carrying heme protein (nitrophorin) of Rhodnius prolixus.

Authors:  J M Ribeiro; F A Walker
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

4.  H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450.

Authors:  F S LaBella; G Queen; G Glavin; G Durant; D Stein; L J Brandes
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

5.  Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.

Authors:  F Watson; D G Deavall; J A Macro; R Kiernan; R Dimaline
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

6.  Antihistaminic drug bromadryl and stimulated platelet aggregation.

Authors:  R Nosál; V Jancinová; M Petríková
Journal:  Agents Actions       Date:  1994-06

7.  Synthesis of intracellular histamine in platelets is associated with activation of protein kinase C, but not with mobilization of Ca2+.

Authors:  S P Saxena; C Robertson; A B Becker; J M Gerrard
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

8.  Neutrophil histamine contributes to inflammation in mycoplasma pneumonia.

Authors:  Xiang Xu; Dongji Zhang; Hong Zhang; Paul J Wolters; Nigel P Killeen; Brandon M Sullivan; Richard M Locksley; Clifford A Lowell; George H Caughey
Journal:  J Exp Med       Date:  2006-12-11       Impact factor: 14.307

9.  Expression and function of histamine and its receptors in atopic dermatitis.

Authors:  M Albrecht; A M Dittrich
Journal:  Mol Cell Pediatr       Date:  2015-12-21

10.  Inducing mitophagy in diabetic platelets protects against severe oxidative stress.

Authors:  Seung Hee Lee; Jing Du; Jeremiah Stitham; Gourg Atteya; Suho Lee; Yaozu Xiang; Dandan Wang; Yu Jin; Kristen L Leslie; Geralyn Spollett; Anup Srivastava; Praveen Mannam; Allison Ostriker; Kathleen A Martin; Wai Ho Tang; John Hwa
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.